Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2025-12-25 @ 9:53 PM
NCT ID: NCT04216251
Description: None
Frequency Threshold: 0
Time Frame: 3 months
Study: NCT04216251
Study Brief: PRevention Using EPA Against coloREctal Cancer
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
AMR101 The first dose of the study medication will be given to patients after the initial flexible sigmoidoscopy. Participants will be expected to take 4 0.5 gram capsules orally, twice daily (daily dose of 4 grams) for a minimum of 8 weeks and maximum of 12 weeks 0 None 1 81 20 81 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Ischemic right foot with thrombosis of right external iliac artery stent and common femoral artery SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE 5.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
GI Upset (i.e. nausea/gas/diarrhea/constipation/stomach ache/loss of appetite) SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE 5.0 View
COVID and Flu-like symptoms (congestion, chills, fever, body ache, headache) SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE 5.0 View
Chest pain SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE 5.0 View
Skin issues (acne, hyperpigmentation) SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE 5.0 View
Pain (joint pain, muscle aches) SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders CTCAE 5.0 View
Esophagitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE 5.0 View